National Prevalence and Impact of Noninvasive Prenatal Testing: Complete Statistical Analysis

1. Trial at a Glance

This page covers the registry results for National Prevalence and Impact of Noninvasive Prenatal Testing (NCT02284399), a registered phase not stated study. The primary outcome is Number of Patient Undergoing IDTFK Before (Control) and After (Test) NIPT Testing Came to Market.

2. Clinical Question

The clinical question is about the number of invasive diagnostic procedures observed across two calendar periods in participating practices. It is not a direct comparison of assigned NIPT versus no NIPT, and the record does not establish that every patient in the later period received NIPT. The study description says that information on women undergoing NIPT would be retrospectively gathered and analyzed, while the specified arms concern women undergoing IDTFK before or after NIPT came to market. Those details frame the question as a change in practice over time, not an estimate of an individual patient’s outcome under alternative testing strategies.

The record does not report the number of IDTFK procedures in either group, a contrast between groups, or uncertainty around that contrast. It therefore cannot establish from the posted results whether the count increased, decreased, or remained similar. The planned comparison is understandable, but the interpretation depends on the actual period-specific counts and on how the populations and observation periods were handled. Those details and results are not reported in the registry record.

3. Trial Design

This is an observational, retrospective comparison of pregnant women who underwent invasive diagnostic testing for fetal karyotype at participating Obstetrix Medical Group outpatient centers. One group represents the period before NIPT came to market, January 2010-July 2010; the other represents the period after NIPT came to market, January 2012-June 2014. The registry lists the study status as completed, enrollment as 4488, a study start of 2014-01, and primary completion on 2016-06-28.

The design uses calendar period as the basis for comparison. The registry does not describe random allocation; this is not a randomized comparison. The two groups are not a like-for-like control comparison simply because they are labeled as pre-NIPT and post-NIPT groups. They were observed in different periods, and factors that changed over time could also affect who was tested and how many procedures took place. The record does not report methods for adjusting for such factors.

The intervention field identifies non-invasive prenatal testing and classifies it as “other.” In this study description, NIPT marks the transition between the earlier and later periods; the record does not report that NIPT itself was assigned to participants. The primary outcome is the number of patients undergoing IDTFK before and after NIPT came to market. A secondary outcome concerns the frequency of positive tests for abnormal karyotype before and after adoption.

The registry gives the primary outcome timeframe as “4 years,” while the arm descriptions identify the specific comparison periods. It does not report the group-specific enrollment, how the count was analyzed, or whether participants could contribute more than one record. It also does not report the protocol, a statistical analysis plan, or a sample-size justification. These omissions limit assessment of how the observed counts were defined and compared.

4. Participant Flow and Accounting

The registry reports how participants moved through each stage of the study. All counts below are exactly as posted; missing counts are not inferred from other stages.

Overall Study

Analysis population for the primary outcome, as defined in the registry: This was an observational study that looked to compare the number of patient who underwent IDTFK during Jan 2010-July 2010 (prior to the adoption of NIPT) with the number of patients who underwent IDTFK during Jan 2012-June 2014 (after the adoption of NIPT).

5. Baseline Characteristics

The table reproduces the baseline characteristics posted in the registry, which describe the participants analysed at baseline and help show whether the randomized groups were comparable.

6. Primary Endpoint

The registry lists the primary outcome as Number of Patient Undergoing IDTFK Before (Control) and After (Test) NIPT Testing Came to Market, measured over 4 years.

The primary endpoint is the count of patients who underwent invasive diagnostic testing for fetal karyotype (IDTFK) in the pre-NIPT and post-NIPT periods. It is a count outcome: it records how many patients had the procedure, rather than measuring a continuous value or the time until an event. In principle, period-specific counts can describe how frequently a service was used in the populations and settings observed.

Counts are relevant to the stated question because the registry asks how the number of IDTFK procedures differed before and after NIPT came to market. However, interpreting counts requires knowing the population or amount of time from which they arose. A raw count can change when the size of the population served, the duration of observation, referral patterns, or the criteria for testing change. Counts alone do not distinguish those explanations. The registry record does not report denominators for the comparison groups or a rate-based analysis.

The primary outcome is not a measure of diagnostic accuracy, patient health, or the effect of NIPT on an individual. The registry also lists the frequency of positive tests for abnormal karyotype as a secondary outcome, but its results are not reported in the registry record. No primary endpoint count or comparison is reported in the registry record, so the observed direction, magnitude, and precision of the primary contrast cannot be described.

7. Why No Re-analysis Is Shown

8. Statistical Interpretation

9. Statistical Methods Explained

The registry describes an observational comparison across two periods, with patients grouped according to when they presented for IDTFK. This is a historical, before-and-after structure: one period precedes the market introduction of NIPT and the other follows it. There is no random allocation reported. The primary endpoint is a count of participants undergoing IDTFK, and the listed secondary endpoint is frequency of positive tests for abnormal karyotype.

What does an observational comparison estimate?

General statistical explanation: an observational comparison describes patterns among people who were observed in different exposure or calendar groups. Unlike random assignment, period membership is not controlled by the study. The measured contrast can reflect the period of interest as well as differences in the people, practices, and circumstances represented in each period. This does not make descriptive counts uninformative, but it means that a causal claim requires evidence and assumptions beyond a difference in counts.

For this record, the comparison is between January 2010-July 2010 and January 2012-June 2014. Those are different observation windows, and the later period spans a longer calendar interval than the earlier period. The registry record does not report a method for standardizing counts for observation time, the number of pregnant patients served, or another denominator. Without that information, a raw count and a rate answer different questions: a count describes the total recorded events, while a rate relates events to a population or time at risk. The posted record does not provide enough result detail to determine which comparison was ultimately reported.

Why do the group counts and denominators matter?

General statistical explanation: counts depend on the size of the population observed. Comparing counts from groups of different sizes can be misleading if the aim is to compare how frequently an event occurs in each population. Analysts may use denominators, rates, or statistical models appropriate to the data structure. The choice depends on how participants were selected, what time they were observed, and whether each participant contributes one or more records.

The overall enrollment is 4488, but group-specific enrollment and outcome counts are not reported in the registry record. It is therefore not possible to check whether the groups were similar in size or to reconstruct a comparison. The registry does not report whether counts were analyzed as raw totals, rates, or another measure, or how repeated observations were handled.

What does uncertainty add?

General statistical explanation: an estimate describes the observed contrast, while an uncertainty measure communicates how much the estimate might vary under a statistical model and its assumptions. A confidence interval is one common uncertainty summary. It is most informative when read alongside the estimate and the design, rather than treated as a separate pass-or-fail result. No estimated contrast, confidence interval, or p-value for the primary endpoint is reported in the registry record.

Counts can have statistical properties that differ from continuous measurements. General explanation: for count data, the spread may not match assumptions of a simple model. Over-dispersion occurs when variability is greater than a model expects; if ignored, uncertainty estimates can be too small. Whether over-dispersion is relevant depends on the data and the selected model. The registry does not report the distribution of the outcome, a modeling approach, or diagnostics, so no claim about over-dispersion or model adequacy can be made for this study.

How should the secondary outcome be read?

The secondary outcome is described as the frequency of positive tests for abnormal karyotype before and after NIPT adoption. General statistical explanation: a frequency can be represented as a count or as a proportion, and those measures have different denominators and interpretations. The record does not report the result, the denominator, or how “frequency” was analyzed. It is therefore not possible to infer whether the yield of positive tests changed or to assess uncertainty around that outcome.

What analysis plan is documented?

The registry record lists no statistical analyses. It does not report a statistical analysis plan, model specification, covariate adjustment, handling of missing data, or sample-size justification. The record includes a general description of a planning illustration based on an observed effect, but no numerical planning results are reported in the registry record. Such illustrations, when available, are planning exercises rather than observed evidence about the outcome. They cannot substitute for the actual group counts or an analysis of the posted data.

In sum, the design and endpoint can be described, but the statistical method used to produce a comparison cannot be reconstructed. Any interpretation beyond the study question would require outcome results and analysis details that are not reported in the registry record.

10. Exact Estimates for Each Arm

No two-arm comparison is shown for this trial, but each arm's result can still be summarized with exact interval estimates computed from the posted counts. The Clopper-Pearson interval is exact and conservative; the Wilson interval is a common closer-to-nominal alternative; the Bayesian credible interval uses a uniform Beta(1, 1) prior. For small groups the three can differ noticeably.

R code and output

arm    <- c("IDTFK Group Pre-NIPT (January 2010-July 2010)", "IDTFK Group Post NIPT - (January 2012-June 2014)")
n      <- c(1414, 3074)
events <- c(1414, 3074)
for (i in seq_along(n)) {
  ci <- binom.test(events[i], n[i])$conf.int          # Clopper-Pearson exact interval
  cr <- qbeta(c(0.025, 0.975), 1 + events[i], 1 + n[i] - events[i])   # Bayesian, uniform Beta(1,1) prior
  wi <- (function(x, n) { p <- x / n; z <- qnorm(0.975); d <- 1 + z^2 / n
    c((p + z^2 / (2 * n) - z * sqrt(p * (1 - p) / n + z^2 / (4 * n^2))) / d, (p + z^2 / (2 * n) + z * sqrt(p * (1 - p) / n + z^2 / (4 * n^2))) / d) })(events[i], n[i])
  cat(sprintf("ARM|%s|%d|%d|%.1f|%.1f|%.1f|%.1f|%.1f|%.1f|%.1f\n", arm[i], n[i], events[i], 100 * events[i] / n[i],
              100 * ci[1], 100 * ci[2], 100 * wi[1], 100 * wi[2], 100 * cr[1], 100 * cr[2]))
}

ARM  IDTFK Group Pre-NIPT (January 2010-July 2010)  1414  1414  100.0  99.7  100.0  99.7  100.0  99.7  100.0
ARM  IDTFK Group Post NIPT - (January 2012-June 2014)  3074  3074  100.0  99.9  100.0  99.9  100.0  99.9  100.0

11. Multiplicity, Missing Data and Analysis Populations

The registry lists two outcome measures: a primary count of patients undergoing IDTFK before and after NIPT came to market, and a secondary outcome concerning the frequency of positive tests for abnormal karyotype before and after adoption. It does not report a statistical analysis for either outcome. The endpoint results, inferential tests, confidence intervals, and analysis populations are not reported in the registry record.

Multiplicity refers, in general, to the increased chance of apparently notable findings when several hypotheses or outcomes are examined. Analysts may address it through prespecified prioritization, adjustment, or careful interpretation. The presence of a named primary and secondary outcome provides an ordering in the registry, but the record does not report a multiplicity strategy or whether additional analyses were planned or conducted. No claim about multiplicity adjustment can therefore be made.

Missing-data methods are also not reported in the registry record. The registry does not describe completeness of records, exclusions, or how unavailable information was handled. Group-specific enrollment and the numbers contributing to each outcome are not reported. This makes it impossible to determine whether all enrolled participants contributed to the primary outcome or whether the analysis population differed from the enrolled population.

The record does not report definitions for an analysis population, such as whether inclusion depended on available clinical records or a specific testing history. It also does not report a protocol or a statistical plan that would clarify whether outcome definitions and analyses were prespecified. These omissions matter for a retrospective study because record availability and inclusion decisions can shape the analyzed groups. They should be treated as undocumented methods, not assumed procedures.

12. What the Result Does, and Does Not, Mean

The registry record establishes that an observational study compared patients undergoing IDTFK at participating practices in a pre-NIPT period and a post-NIPT period. It identifies 4488 as total enrollment and lists the primary outcome as a count of patients undergoing the procedure. These details describe the study question and setting, but they do not give the primary outcome result.

The record does not show how many patients underwent IDTFK in either period, whether the counts differed, or how uncertain any comparison was. It therefore does not support a statement that the number of procedures rose, fell, or stayed the same. It also does not report the frequency of positive tests for abnormal karyotype. The completed status does not fill this result gap.

General statistical explanation: even when a difference in counts is available, a before-and-after observational comparison is not automatically evidence that the change was caused by the event marking the periods. Other differences over time, including the size and composition of the populations observed, may matter. This record does not report adjustment for potential temporal differences. The design can describe practice patterns in the included settings, but causal attribution would require additional evidence and assumptions.

The adverse-event entries list zero serious events, other events, and deaths for each group in their reported count fields. Those entries should be read as registry reporting, not as proof that no adverse events occurred or as a comprehensive safety evaluation. The registry does not provide further adverse-event detail.

Accordingly, the central statistical message is limited: the comparison is defined, but its outcome results are not reported in the registry record. No treatment recommendation or conclusion about the effectiveness or safety of NIPT follows from the information posted.

13. Why This Trial Matters Statistically

This study asks a health-services question: how many patients underwent invasive diagnostic testing for fetal karyotype in participating practices before and after NIPT came to market? Counts of procedures can be relevant to understanding changes in clinical practice. The record also identifies a secondary question about the frequency of positive tests for abnormal karyotype. Together, these questions distinguish use of a procedure from the findings among those tested.

Statistically, the comparison illustrates why a before-and-after design needs careful description. A count is interpretable in relation to who could be counted, the time window, and the population served. The periods identified in the registry are not alike in duration, and group sizes and denominators are not reported. Without outcome results and those contextual details, readers cannot determine how procedure use differed or what the counts represent relative to the underlying population.

The study is also a useful example of the distinction between a registry record being marked completed and results being available for interpretation. The record gives enrollment, study periods, endpoints, and status, but does not report the primary or secondary outcome results or a statistical analysis. A clear research question is not itself evidence of the direction or size of an outcome.

Because NIPT is the marker for the two periods rather than a randomized assignment described in the record, any observed difference would require cautious interpretation. Calendar-time comparisons can capture broader changes in practice as well as changes associated with a new testing option. The record does not report methods that separate those possibilities. The statistical importance of the study lies in the question it frames and in the limits on inference when results and denominators are unavailable—not in a demonstrated effect, which cannot be assessed from this record.

14. Limitations

• The posted summary statistics are the only data these results rest on; patient-level data, full protocols and statistical analysis plans are not available.
• Recalculated results are simple, unadjusted calculations from posted summaries. They do not replace the sponsor's prespecified analysis.

The main limitation for interpreting this study is that outcome results are not reported in the registry record. The primary count for each period, the comparison between periods, and uncertainty estimates are unavailable. The secondary outcome is listed without results as well. As a result, the study’s observed findings cannot be described from this record.

The comparison is observational and uses different calendar periods. The registry does not report random allocation, adjustment for changes over time, or methods for addressing differences between the groups. The groups therefore should not be treated as equivalent apart from NIPT availability. The record also does not report group-specific enrollment, denominators, or a rate-based analysis, limiting interpretation of raw counts across the stated periods.

The registry does not report detailed inclusion criteria beyond the descriptions of patients presenting to participating centers and undergoing IDTFK. It does not explain how retrospective records were identified, whether records were complete, how missing data were handled, or how the analysis population was defined. The listed timeframe of “4 years” and the period descriptions do not by themselves explain the analytic exposure time for each group.

No statistical analysis plan, model, covariate adjustment strategy, multiplicity approach, or sample-size justification is reported in the registry record. The record lists zero counts in adverse-event fields for both groups but does not provide enough detail to interpret those entries as a comprehensive safety assessment. Finally, findings from participating outpatient centers may not describe other settings; the registry does not report information that would establish broader representativeness.

15. Related Tutorials

16. Related Statistical Calculators

17. Sources

• ClinicalTrials.gov: National Prevalence and Impact of Noninvasive Prenatal Testing — NCT02284399.
• Registry record last updated 2019-06-19; status last verified 2019-03.
• Results first posted 2019-06-19.
• Data retrieved from ClinicalTrials.gov on 2026-11-09.
• Group sizes, means, event counts and sponsor-reported p-values are reproduced as posted. Effect estimates, confidence intervals and p-values not attributed to the sponsor are independently calculated from the posted summary statistics.

18. Record Summary

The registry describes a completed observational study sponsored by Obstetrix Medical Group, with enrollment of 4488 and primary completion on 2016-06-28. It compares pregnant women undergoing IDTFK at participating outpatient centers in January 2010-July 2010, before NIPT came to market, with those undergoing the procedure in January 2012-June 2014, after it came to market.

The primary outcome is the number of patients undergoing IDTFK in the two periods. A secondary outcome concerns the frequency of positive tests for abnormal karyotype. The primary and secondary results, group-specific counts, statistical analyses, and analysis methods are not reported in the registry record. The record is observational and does not describe random allocation.

The adverse-event record lists zero in its reported count fields for both groups. Those entries do not establish that no events occurred. The study question and design are identifiable, but the posted information is insufficient to assess the direction, magnitude, or precision of the primary comparison.